Back to search

Article

Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)

2023-01-24

Abstract excerpt

<title>Abstract</title> <p>Background: Angelman syndrome (AS) is a rare neurodevelopmental disorder with developmental, behavioral, and medical challenges caused by absence of functional UBE3A. AS has unmet treatment needs and no approved therapies address its underlying pathophysiology. To develop new therapies, comprehensive data are needed for identification of appropriate endpoints to assess meaningful impro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3a77a9f5-f88b-5827-a4a7-ab542060db6d
DOI
10.21203/rs.3.rs-2484857/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS)DOI 10.21203/rs.3.rs-2484857/v1
Select a neighboring publication to make it the new centre.